A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia

Author： Papanicolaou Dimitris   Ather S.   Zhu H.   Zhou Y.   Lutkiewicz J.   Scott B.   Chandler J.  

Publisher： Springer Publishing Company

ISSN： 1279-7707

Source： The journal of nutrition, health & aging, Vol.17, Iss.6, 2013-06, pp. : 533-543

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effects of Selective Androgen Receptor Modulator (SARM) Treatment in Osteopenic Female Rats

By Kearbey Jeffrey   Gao Wenqing   Fisher Scott   Wu Di   Miller Duane   Dalton James  

Pharmaceutical Research, Vol. 26, Iss. 11, 2009-11 ,pp. : 2471-2477

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Safety of Topical Alprostadil Cream for the Treatment of Female Sexual Arousal Disorder (FSAD): A Double-Blind, Multicenter, Randomized, and Placebo-Controlled Clinical Trial

By PADMA-NATHAN HARIN   BROWN CANDACE   FENDL JANE   SALEM SHAWKI   YEAGER JAMES   HARNINGR RONALD  

Journal of Sex & Marital Therapy, Vol. 29, Iss. 5, 2003-01 ,pp. : 329-344

Routledge Ltd

Access to resources Recommend Favorite

Tolvaptan in hospitalized cancer patients with hyponatremia: A double‐blind, randomized, placebo‐controlled clinical trial on efficacy and safety

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 744-751

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of fasiglifam (TAK‐875), a G protein‐coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double‐blind, placebo‐controlled, phase III trial

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 7, 2015-07 ,pp. : 675-681

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Efficacy and Safety of Blonanserin Compared with Haloperidol in Acute-Phase Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Multicentre Study

By Garcia Esther  

CNS Drugs, Vol. 23, Iss. 7, 2009-07 ,pp. : 615-625

Adis International

Access to resources Recommend Favorite